Kim Janda - Dec 27, 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Stock symbol
SRNEQ
Transactions as of
Dec 27, 2021
Transactions value $
-$5,640
Form type
4
Date filed
12/27/2021, 06:34 PM
Previous filing
Sep 28, 2021
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Options Exercise $12K +3K +100% $4.00* 6K Dec 27, 2021 Direct F1
transaction SRNEQ Common Stock Sale -$17.6K -3K -50% $5.88* 3K Dec 27, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Non-qualified stock option Options Exercise $0 -3K -100% $0.00* 0 Dec 27, 2021 Common Stock 3K $4.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.